InvestorsHub Logo
Followers 2
Posts 119
Boards Moderated 0
Alias Born 09/20/2017

Re: Fress post# 1456

Monday, 05/20/2019 5:58:13 AM

Monday, May 20, 2019 5:58:13 AM

Post# of 2676
I wonder if OTC availability of certain CBD products can pose a meaningful competitive threat to Zyne's ability to control the approved medicinal applications. Probably not, but not certain.
Is it certain that the production cost of synthetic CBD (and THC) is substantially lower than the production cost from the plant? I would guess so, but have no confirmation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News